BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

New Hartley Analyst report on Bot, page-28

  1. 1,513 Posts.
    lightbulb Created with Sketch. 437
    That argument only makes sense if a new competitor is launched into the market ahead of our new timeline. Otherwise you would model the take up rate exactly the same way, and the only loss is a few months of revenue.

    Also 3-6 months is not almost 12 months. Words are important.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.